Insecticides India Ltd
₹520.10
-16.05 (2.99%)
Sun, 25 Oct 2026, 08:00 pm
Process Industries
Chemicals: Agricultural
24.5KInsecticides India EV/EBITDA Ratio
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 3.95 | 2.05 | 5.46 | 11.77 | 15.75 | 14.45 | 7 | 15.98 | 16.28 | 18.39 | 16.88 | 11.10 | 7.45 | 10.43 | 11.33 | 21.88 | 14.17 | 12.24 |
| Price to book ratio | 0 | 0 | 0.71 | 0.42 | 1.22 | 2.45 | 2.86 | 2.41 | 1.15 | 3.03 | 1.58 | 2.36 | 2.60 | 2.06 | 0.88 | 1.19 | 1.39 | 1.51 | 1.43 | 1.59 |
| Price to sales ratio | 0 | 0 | 0.32 | 0.18 | 0.44 | 0.94 | 1.09 | 0.90 | 0.35 | 0.98 | 0.71 | 1.10 | 1.33 | 1.14 | 0.47 | 0.69 | 0.81 | 0.77 | 0.74 | 0.87 |
| Price to cash flow ratio | 0 | 0 | 0 | 5.55 | 0 | 10.40 | 0 | 0 | 13.08 | 0 | 9.80 | 0 | 8.57 | 0 | 2.96 | 6.47 | 9.46 | 0 | 8.19 | 19.51 |
| Enterprise value | 0 | 0 | 67.35Cr | 53.8Cr | 167Cr | 413Cr | 661Cr | 717Cr | 528Cr | 1191Cr | 838Cr | 1325Cr | 1517Cr | 1659Cr | 764Cr | 996Cr | 1235Cr | 1526Cr | 1469Cr | 1776Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 3.87 | 1.98 | 5.04 | 9.75 | 11.66 | 10.44 | 6.44 | 10.70 | 9.06 | 11.53 | 10.33 | 8.52 | 4.69 | 7.16 | 7.30 | 11.51 | 9.42 | 7.97 |
| Debt to equity ratio | 0.45 | 0.41 | 0.19 | 0.14 | 0.17 | 0.25 | 0.87 | 1 | 1.06 | 1.11 | 0.50 | 0.51 | 0.21 | 0.46 | 0.26 | 0.12 | 0.06 | 0.18 | 0.09 | 0.10 |
| Return on equity % | 51.16 | 28.87 | 24.48 | 22.72 | 24.84 | 22.93 | 19.60 | 17.91 | 17.51 | 20.57 | 11.37 | 13.70 | 16.61 | 20.30 | 12.47 | 12.10 | 12.71 | 7.07 | 10.58 | 13.54 |
Insecticides India Ltd Enterprise Value to EBITDA Ratio
The Insecticides India Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Insecticides India Ltd's valuation, profitability, and overall financial performance. Tracking the Insecticides India Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Insecticides India Ltd (NSE: INSECTICID, BSE: 532851) is currently trading at ₹520.10, with a market capitalization of ₹1507.12Cr. As a leading company in the Process industries sector and Chemicals: agricultural industry, monitoring the Insecticides India Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Insecticides India Ltd Enterprise Value to EBITDA Ratio Current Value
The current Insecticides India Ltd Enterprise Value to EBITDA Ratio stands at 7.97.
The Insecticides India Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Insecticides India Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Insecticides India Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2025: 7.97
- 2024: 9.42
- 2023: 11.51
- 2022: 7.30
- 2021: 7.16
The decline in Insecticides India Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Insecticides India Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Insecticides India Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Insecticides India Ltd.
Insecticides India Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Insecticides India Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Insecticides India Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Insecticides India Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
